Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and …
Over the last 12 months, insiders at Integra LifeSciences Holdings Corporation have bought $2.5M and sold $331,193 worth of Integra LifeSciences Holdings Corporation stock.
On average, over the past 5 years, insiders at Integra LifeSciences Holdings Corporation have bought $1.45M and sold $63.15M worth of stock each year.
Highest buying activity among insiders over the last 12 months: ESSIG STUART (Exec. Chairman of the Board) — $3M. HILL BARBARA B (director) — $995,816.
The last purchase of 52,641 shares for transaction amount of $1.5M was made by ESSIG STUART (Exec. Chairman of the Board) on 2024‑05‑23.
2024-08-19 | Sale | SVP, Fin & Princ Acct Officer | 1,191 0.0015% | $21.58 | $25,701 | -10.53% | ||
2024-05-23 | Exec. Chairman of the Board | 52,641 0.0668% | $28.49 | $1.5M | -24.10% | |||
2024-05-21 | director | 36,350 0.0462% | $27.40 | $995,816 | -20.66% | |||
2024-03-06 | Sale | EVP & President, TT | 8,348 0.0109% | $36.59 | $305,492 | -23.84% | ||
2023-08-09 | Sale | SVP, Fin & PAO | 1,177 0.0014% | $44.46 | $52,329 | -14.14% | ||
2023-06-01 | EVP, Chief Legal Officer & Sec | 2,640 0.0032% | $37.89 | $100,035 | +2.88% | |||
2023-06-01 | President & CEO | 7,792 0.0095% | $38.50 | $299,986 | +2.88% | |||
2023-03-07 | Sale | EVP & President, CSS | 1,843 0.0023% | $54.29 | $100,064 | -22.92% | ||
2023-03-01 | Sale | EVP & President, TT | 1,566 0.0019% | $55.21 | $86,463 | -23.04% | ||
2023-02-27 | Sale | EVP & CHRO | 3,767 0.0046% | $57.00 | $214,731 | -25.99% | ||
2022-12-08 | Sale | SVP, Fin & Princ Acct Officer | 279 0.0003% | $56.22 | $15,684 | -21.21% | ||
2022-08-10 | Sale | Executive Vice President &CHRO | 1,165 0.0014% | $55.81 | $65,020 | -6.92% | ||
2022-08-05 | Sale | 8,000 0.0096% | $55.78 | $446,266 | -5.72% | |||
2022-08-02 | Sale | SVP, Fin & Princ Acct Officer | 437 0.0005% | $56.77 | $24,811 | -5.27% | ||
2022-06-15 | Sale | Executive Vice President &CHRO | 900 0.0011% | $55.93 | $50,337 | -3.92% | ||
2022-05-24 | Sale | Executive Vice President &CHRO | 250 0.0003% | $59.85 | $14,963 | -8.85% | ||
2022-04-04 | Sale | Executive Vice President & COO | 6,268 0.0077% | $66.04 | $413,939 | -14.16% | ||
2022-03-23 | Sale | 10 percent owner | 150,000 0.1845% | $64.67 | $9.7M | -11.66% | ||
2022-02-28 | Sale | Executive Vice President &CHRO | 1,254 0.0015% | $67.03 | $84,056 | -16.22% | ||
2022-02-09 | Sale | 10 percent owner | 75,000 0.0891% | $65.82 | $4.94M | -15.02% |
ESSIG STUART | Exec. Chairman of the Board | 487922 0.6323% | $22.95 | 1 | 74 | |
HILL BARBARA B | director | 36350 0.0471% | $22.95 | 4 | 0 | +10.78% |
CARUSO RICHARD E | 10 percent owner | 10291205 13.3369% | $22.95 | 1 | 12 | +23.04% |
Schwartz Eric | EVP, Chief Legal Officer & Sec | 48597 0.063% | $22.95 | 1 | 3 | +2.88% |
MOREL DONALD E JR | director | 37112 0.0481% | $22.95 | 2 | 0 | +6.47% |
The Vanguard Group | $247.47M | 8.86 | 6.98M | -0.46% | -$1.14M | 0.01 | |
BlackRock | $235.66M | 8.44 | 6.65M | +0.09% | +$209,615.85 | 0.01 | |
Capital Research Global Investors | $209.83M | 7.51 | 5.92M | +37.74% | +$57.49M | 0.05 | |
Morgan Stanley | $174.22M | 6.24 | 4.91M | -6.76% | -$12.63M | 0.01 | |
Wellington Management Company | $118.35M | 4.24 | 3.34M | +4.81% | +$5.43M | 0.02 |